Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LUCYW | US
-0.01
-12.34%
Healthcare
Medical Instruments & Supplies
30/06/2024
04/10/2024
0.05
0.04
0.05
0.04
Innovative Eyewear Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music take and make calls and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. The company sells its products through various e-commerce and retail distribution channels. Innovative Eyewear Inc. has a partnership with Lucyd. The company was founded in 2019 and is headquartered in North Miami Florida. Innovative Eyewear Inc. operates as a subsidiary of Lucyd Ltd.
View LessPositive Momentum
Strong Revenue Growth (> 10%)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
311.4%1 month
408.6%3 months
459.3%6 months
471.0%-
-
-
-
-
-
-
-
-8.01M
-
-
-
-639.61
-
81.70
-96.53
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.04
Range1M
0.05
Range3M
0.17
Rel. volume
0.84
Price X volume
926.10
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Pheton Holdings Ltd Class A Ordinary Shares | PTHL | Medical Devices | 5.79 | 0 | -10.09% | n/a | |
Cesca Therapeutics Inc | KOOL | Medical Devices | 10.77 | 0 | 0.65% | n/a | |
WORK Medical Technology Group LTD Ordinary Shares | WOK | Medical Devices | 4.71 | 0 | -3.88% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
No data |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | - | 7.69 | - |
Ent. to Revenue | - | 64.13 | - |
PE Ratio | - | 50.95 | - |
Price to Book | - | 6.11 | - |
Dividend Yield | - | 1.34 | - |
Std. Deviation (3M) | 459.30 | 55.82 | Riskier |
Debt to Equity | - | 0.86 | - |
Debt to Assets | - | 0.26 | - |
Market Cap | - | 9.95B | - |